EMC3 as a Novel Biomarker and Driver of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Progression
Authors:
- 5 November 2025
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (3) , 2169-2188
Abstract
Endoplasmic reticulum membrane protein complex subunit 3 (EMC3) plays a critical role in protein translocation and processing and has been implicated in muKeywords
Funding Information
- the project of the Department of Education of Henan Province (SB201904006)
- Liver and Biliary Mutual Aid Fund of Henan Province Charity Federation (GDXZ2019003)
- Joint Construction Project of Medical Science and Technology of Henan Province (LHGJ20220316)
This publication has 49 references indexed in Scilit:
- APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024Hepatology International, 2024
- The evolving tumor microenvironment: From cancer initiation to metastatic outgrowthCancer Cell, 2023
- Functional characterization of 5p15.33 risk locus in uveal melanoma reveals rs452384 as a functional variant and NKX2.4 as an allele-specific interactorThe American Journal of Human Genetics, 2022
- Turning tumors from cold to inflamed to improve immunotherapy responseCancer Treatment Reviews, 2021
- The ER membrane protein complex subunit Emc3 controls angiogenesis via the FZD4/WNT signaling axisScience China Life Sciences, 2021
- Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2018
- The PI3K Pathway in Human DiseaseCell, 2017
- AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinomaBiochemical and Biophysical Research Communications, 2017
- Proteoglycans and neoplasiaCancer and Metastasis Reviews, 1988
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983